Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UDP glucuronosyltransferase family 1 member A12, pseudogene (UGT1A12P), is a genomic DNA sequence classified as a pseudogene in humans. It is part of the UGT1 gene complex, which includes both functional enzymes and pseudogenes involved in glucuronidation. Pseudogenes like UGT1A12P resemble the structure of protein-coding genes but lack protein-coding capability due to mutations or premature stop codons; therefore, they do not encode a functional enzyme and have no established biological function or disease association[7][1]. UGT1A12P should not be confused with other functional members of the UGT1 family, which are critical drug-metabolizing enzymes[4][5][6].\n\nNotes:\n- UGT1A12P is a pseudogene and does not code for a functional protein[7]. It is not considered a therapeutic target or biomarker.\n- No role in drug interaction, disease, or therapy has been established for this pseudogene.\n- Its name and aliases may resemble those of functional UDP-glucuronosyltransferase enzymes, but they should not be conflated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UDP glucuronosyltransferase family 1 member A12, pseudogene (UGT1A12P).